Physostigmine should be used more readily for antimuscarinic toxicity: CON

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	61-63
Number of pages	3
Journal	British Journal of Clinical Pharmacology
Volume	88
Issue number	1
DOIs	https://doi.org/10.1111/bcp.15121
State	Published - Jan 2022

Access to Document

@article{7d73c45a9bae4e05a917aead95acb62b,

title = "Physostigmine should be used more readily for antimuscarinic toxicity: CON",

author = "Mullins, {Michael E.}",

year = "2022",

month = jan,

doi = "10.1111/bcp.15121",

language = "English",

volume = "88",

pages = "61--63",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

number = "1",

}

TY - JOUR

T1 - Physostigmine should be used more readily for antimuscarinic toxicity

T2 - CON

AU - Mullins, Michael E.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85119059637&partnerID=8YFLogxK

U2 - 10.1111/bcp.15121

DO - 10.1111/bcp.15121

M3 - Article

C2 - 34784063

AN - SCOPUS:85119059637

SN - 0306-5251

VL - 88

SP - 61

EP - 63

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 1

ER -